Vicarious Surgical Inc. (RBOT) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Vicarious Surgical Inc. faces significant business risk due to its failure to meet the NYSE’s minimum average share price requirement, receiving a notice on September 20, 2023, for its Class A common stock’s performance. The company has six months to regain compliance, with potential strategies including a reverse stock split. However, investor concerns over possible delisting could negatively impact stock value and trading volume, with severe consequences such as diminished market liquidity and impaired financing capabilities. Delisting could also erode stakeholder confidence and reduce business prospects, further harming the company’s market position and investment attractiveness.
The average RBOT stock price target is $1.00, implying 182.65% upside potential.
To learn more about Vicarious Surgical Inc.’s risk factors, click here.
